Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Aspen Pharma of South Africa to Expand in China via Partnerships

publication date: Nov 27, 2017

Aspen Holdings, a South African generic drug company, plans to establish partnerships to build its China drug portfolio, according to management. The company established a China presence by acquiring anesthetic and thrombosis drugs from AstraZeneca and GlaxoSmithKline in 2016. With 650 staff, China is now Aspen's largest regional office. It has opened "key" sales offices in Beijing, Shanghai and Guangzhou, and is now ready to expand, the company said. More details....

Stock Symbols: (NYSE: AZN) (NYSE: GSK)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital